scholarly journals Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity

2009 ◽  
Vol 32 (6) ◽  
pp. 238 ◽  
Author(s):  
Xiao Meng ◽  
Liangyi Qie ◽  
Yuanyuan Wang ◽  
Ming Zhong ◽  
Li Li

Purpose: Several studies have shown arterial stiffness changes associated with coronary artery disease (CAD). Recently, statins were reported to improve arterial stiffness. The aim of the study was to evaluate the effect of atorvastatin on arterial stiffness in CAD patients using pulse wave velocity (PWV). Methods: We evaluated 63 patients with hyperlipemia and CAD. Forty-three patients were given 10mg atorvastatin daily and 20 patients were assigned to a low-fat diet. Carotid-femoral PWV (PWV-CF), carotid-radial PWV (PWV-CR) and carotid-distal PWV (PWV-CD) were measured in all patients. Results: Compared with baseline, PWV-CF, PWV-CR and PWV-CD decreased after therapy in the atorvastatin group (13.22±3.39 & 11.85±2.87; 11.85±2.72 & 10.73±2.31; and 11.04±1.99 & 10.15±1.75, P < 0.05). There was no difference in the control group (13.29±2.89 & 13.93±2.89; 11.52±2.25 & 12.31±2.22; and 10.46±1.86 & 11.15±1.85, P > 0.05). After treatment, values of total cholesterol, triglyceride and low density lipoprotein (LDL) cholesterol were reduced in the 2 groups (P < 0.05). Conclusions: The study demonstrated that atorvastatin can improve arterial stiffness in CAD patients independent of its lipid-lowering properties.

2014 ◽  
Vol 348 (4) ◽  
pp. 294-299 ◽  
Author(s):  
Chang-Min Chung ◽  
Teng-Yao Yang ◽  
Yu-Sheng Lin ◽  
Shih-Tai Chang ◽  
Ju-Feng Hsiao ◽  
...  

2014 ◽  
pp. 429-437
Author(s):  
Z. LENKEY ◽  
M. ILLYÉS ◽  
R. BÖCSKEI ◽  
R. HUSZNAI ◽  
Z. SÁRSZEGI ◽  
...  

Recently an expert consensus document advised to standardize user procedures and a new cut-off value for carotid-femoral pulse wave velocity in daily practice. Our aim was to observe aortic pulse wave velocity (PWVao) and augmentation index (AIXao) in two high cardiovascular risk groups: patients with verified coronary artery disease (CAD) or with type 2 diabetes mellitus (T2DM). We also aimed to determine the cut-off values for PWVao, AIXao in CAD and T2DM patients using oscillometric device (Arteriograph). We investigated 186 CAD and 152 T2DM patients. PWVao and AIXao increased significantly in the CAD group compared to the age-, gender-, blood pressure-, and heart rate-matched control group (10.2±2.3 vs. 9.3±1.5 m/s; p<0.001 and 34.9±14.6 vs. 31.9±12.8 %; p<0.05, respectively). When compared to the apparently healthy control subjects, T2DM patients had significantly elevated PWVao (9.7±1.7 vs. 9.3±1.5 m/s; p<0.05, respectively), however the AIXao did not differ significantly. The ROC-curves of CAD and healthy control subjects explored cut-off values of 10.2 m/s for PWVao and 33.23 % for AIXao. Our data provide supporting evidence about impaired arterial stiffness parameters in CAD and T2DM. Our findings encourage the implementation of arterial stiffness measurements by oscillometric method in daily clinical routine.


2006 ◽  
Vol 36 (8) ◽  
pp. 565 ◽  
Author(s):  
Young-Soo Lee ◽  
Kee-Sik Kim ◽  
Chang-Wook Nam ◽  
Seong-Wook Han ◽  
Seung-Ho Hur ◽  
...  

2014 ◽  
Vol 16 (9) ◽  
pp. 629-633 ◽  
Author(s):  
Britt Hofmann ◽  
Marcus Riemer ◽  
Christian Erbs ◽  
Alexander Plehn ◽  
Alexander Navarrete Santos ◽  
...  

Heart Asia ◽  
2014 ◽  
Vol 6 (1) ◽  
pp. 109-115 ◽  
Author(s):  
R. Ranjith ◽  
T. G. Binu ◽  
V. George ◽  
K. G. Madhu ◽  
P. Devika ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document